Anaheim, CA-Evidence-based medicine is at least a partial solution to many of the dilemmas facing today's ophthalmologists.
What ophthalmologists need to know about neuromyelitis optica spectrum disorder
Uncovering Neurotrophic Keratitis: Exploring Hidden Manifestations and Key Patient Demographics
FDA approves faricimab-svoa 6.0 mg single-dose prefilled syringe for use in the treatment of wet AMD, DME and RVO
Mastering the New Treatment Paradigm in Geographic Atrophy – From Detection to Intervention
Beacon Therapeutics treats first patient in VISTA registrational trial for AGTC-501
Pegcetacoplan injection preserves visual function at 36 weeks in patients with geographic atrophy